To provide a thorough assessment, this meta-analysis aims to measure the efficacy of different immunotherapies in pediatric T1DM patients by measuring their average C peptide levels, daily dosage of insulin, and HbA1c levels. This evidence concerns the gene INS and type 1 diabetes mellitus.